Keyphrases
Novel Therapeutics
100%
Metastatic Cancer
100%
Mucin 1 (MUC1)
100%
Decoy Peptide
100%
Protein Transduction Domain
66%
Inhibitory Peptide
60%
Metastatic Breast Cancer
33%
Arizona
20%
Anticancer Drugs
13%
Tumor-specific
13%
Intracellular Interactions
13%
Therapeutic Proteins
13%
Cancer Therapeutics
13%
Clinical Trials
13%
In Cancer
6%
No Toxicity
6%
Laboratory Research
6%
Cellular Uptake
6%
Peptide-based
6%
Human Breast Carcinoma
6%
Absorption Distribution
6%
Antitumor
6%
Breast Cancer Progression
6%
Effective Treatment
6%
Chemotherapy
6%
First-in-class
6%
Disability Burden
6%
Over 40
6%
Tumor Growth
6%
Disease Burden
6%
Drug Toxicity
6%
Treatment Options
6%
Immune Response
6%
Epidermal Growth Factor Receptor
6%
Anti-MUC1
6%
Drug Dosing
6%
Intracellular Targets
6%
Drug Absorption
6%
FDA-approved Drugs
6%
Tumor Therapeutics
6%
Tumor-bearing Mice Model
6%
Preclinical Research
6%
Decoy
6%
Breast Cancer Growth
6%
Metabolism
6%
Tumor-promoting
6%
Breast Cancer
6%
Tumor Metastasis
6%
Transmembrane
6%
Oncoprotein
6%
Carry-and-forward
6%
Drug Candidates
6%
Low Toxicity
6%
Cancer Center
6%
Pharmacology, Toxicology and Pharmaceutical Science
Metastasis
100%
Mucin 1
100%
Neoplasm
43%
Metastatic Breast Cancer
25%
Malignant Neoplasm
25%
Breast Cancer
18%
Cancer Growth
12%
Clinical Trial
12%
Preclinical Study
12%
Oncoprotein
6%
Breast Carcinoma
6%
Chemotherapy
6%
Epidermal Growth Factor Receptor
6%
Disease
6%
Tumor Growth
6%
Mouse Model
6%
Biochemistry, Genetics and Molecular Biology
MUC1
100%
Clinical Trial
12%
Preclinical Study
12%
Therapeutic Protein
12%
Absorption
6%
Tumor Progression
6%
Cooperation
6%
Mouse Model
6%
Immune Response
6%
Transport Protein
6%
Metabolic Pathway
6%
Epidermal Growth Factor Receptor
6%